Thus, methylation analyses of CADM1, MAL, and miR124 seem to be able to distinguish hrHPV-positive patients with transforming lesions at short-term risk of progression from women with clinically irrelevant infections [11,15,16]. The gene discussed is CADM1; the disease is infection.